Lamya Hamad
Impact in
-
- Medication Adherence and Compliance
-
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
- Oncology 7
- Cancer Immunotherapy and Biomarkers 5
- Pancreatic and Hepatic Oncology Research 1
- Cancer Treatment and Pharmacology 1
-
- Advanced Breast Cancer Therapies 2
- Co-authors
- Marc S. Ernstoff (3 shared papers)Chong Wang (2 shared papers)Manu Pandey (2 shared papers)Shipra Gandhi (2 shared papers)Yara Abdou (1 shared paper)Ankita Kapoor (1 shared paper)Mark J. Bucsek (1 shared paper)Elizabeth Repasky (1 shared paper)
- Journals
- Journal of Clinical Oncology (2 papers)Diabetes Research and Clinical Practice (1 paper)Medicine (1 paper)Journal of Oncology Practice (1 paper)Journal of Oncology Pharmacy Practice (1 paper)
- Partner nations
- United States
In The Last Decade
Lamya Hamad
9 papers receiving 97 citations
Peers
Comparison fields: 5 of 43
- Family Practice 5
- Oncology 39
- Emergency Medical Services 5
- Psychiatry and Mental health 10
- Cancer Research 10
Countries citing papers authored by Lamya Hamad
This map shows the geographic impact of Lamya Hamad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lamya Hamad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lamya Hamad more than expected).
Fields of papers citing papers by Lamya Hamad
This network shows the impact of papers produced by Lamya Hamad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lamya Hamad. The network helps show where Lamya Hamad may publish in the future.
Co-authors
The 18 scholars most cited alongside Lamya Hamad, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 33 | |
| 2 | 2020 | 27 | |
| 3 | 2023 | 11 | |
| 4 | 2019 | 10 | |
| 5 | 2016 | 9 | |
| 6 | 2016 | 5 | |
| 7 | 2017 | 2 | |
| 8 | 2023 | 1 | |
| 9 | 2020 | 1 | |
| 10 | 2024 | 0 |
About Lamya Hamad
Lamya Hamad is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Infectious Diseases, Molecular Biology and Nephrology, having authored 10 papers that have together received 99 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (5 papers), Advanced Breast Cancer Therapies (2 papers), Pancreatic and Hepatic Oncology Research (1 paper), Immunotherapy and Immune Responses (1 paper), Antifungal resistance and susceptibility (1 paper), Chemotherapy-induced cardiotoxicity and mitigation (1 paper), Medication Adherence and Compliance (1 paper) and Cancer Treatment and Pharmacology (1 paper). The work is most often cited by research in Family Practice (5 citations), Oncology (39 citations), Emergency Medical Services (5 citations), Psychiatry and Mental health (10 citations) and Cancer Research (10 citations). Lamya Hamad has collaborated with scholars based in United States. Frequent co-authors include Marc S. Ernstoff, Chong Wang, Manu Pandey, Shipra Gandhi, Yara Abdou, Ankita Kapoor, Mark J. Bucsek, Elizabeth Repasky, Kilian Salerno and Kristopher Attwood. Their work appears in journals such as Journal of Clinical Oncology, Diabetes Research and Clinical Practice, Medicine, Journal of Oncology Practice and Journal of Oncology Pharmacy Practice.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.